Private Equity Firm Healthcare

SV Health Investors

Boston, Massachusetts, United States

Specialist healthcare fund manager investing across stages, geographic regions, and sectors, with expertise spanning biotechnology, dementia therapeutics, healthcare growth, and healthcare technology. Also manages the Dementia Discovery Fund (DDF), focused on discovering and developing novel therapeutics for dementia.

Focus Areas
Biotechnology, Dementia therapeutics, Healthcare growth

Tracked deals

13

13 tracked deals across 2019-2026.

Recent pace

2

2 tracked deals announced in the last 12 months.

Deal mix

Addon

6 addon · 4 buyout · 2 growth capital

SV Health Investors Acquisition Volume by Year

Last 7 years

Acquisition volume by year Annual acquisition counts for the last 7 years for SV Health Investors. 1 2019 1 2020 4 2021 1 2022 1 2024 3 2025 ~2 est. 2 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

Showing the 12 most recent of 13 tracked deals for SV Health Investors.

  • Buyer
    SV Health Investors
    Target
    EpiVax, Inc.
    Type
    Buyout

    SV Health Investors (SVHI) announced the acquisition of EpiVax, a Providence, Rhode Island-based bioanalytical CRO specializing in immunogenicity risk assessments for pharmaceutical and biotech companies. The deal is positioned as SVHI’s new platform investment to expand SVHI’s tech-enabled pharma services offering, with EpiVax planning new computational tools, cell-based assay applications, and expanded analytical consulting services.

  • Buyer
    HLM Investment Partners, Escalate Capital Partners, RVM Enterprises, SV Health Investors
    Target
    HPS/PayMedix

    HPS/PayMedix closed $33 million of equity and debt financing to accelerate national growth of its healthcare financing and payments platform. The round was led by HLM Investment Partners ($16M growth equity) and included Escalate Capital Partners (providing a $17M term debt facility), RVM Enterprises, and existing investor SV Health Investors.

  • Buyer
    Packaging Compliance Labs, SV Health Investors
    Target
    Quest Engineering Solutions
    Type
    Addon

    Packaging Compliance Labs (PCL), a PE-backed provider of sterile packaging and testing services, has acquired Quest Engineering Solutions, an ISO 17025-accredited test lab based in Billerica, Massachusetts. The add-on expands PCL's East Coast footprint and broadens its testing capabilities for medical device and life sciences customers; PCL is backed by SV Health Investors.

  • Buyer
    Centauri Health Solutions, Abry Partners, Silversmith Capital Partners, SV Health Investors
    Target
    MedAllies
    Type
    Buyout

    Centauri Health Solutions, a Phoenix-based health information technology company, has acquired MedAllies, a New York-based Health Information Service Provider (HISP) and Qualified Health Information Network (QHIN). The deal expands Centauri's clinical exchange network by adding MedAllies' connectivity, messaging and record-location capabilities and brings access to more than 1,000 hospitals, 5,000 ambulatory organizations and 125,000 healthcare providers.

  • Buyer
    Peloton Equity, SV Health Investors, BPEA Private Equity, SOSV
    Target
    Ria Health

    Ria Health, a San Francisco–based telehealth provider of evidence-based alcohol use disorder (AUD) treatment, closed a Series B growth equity round led by Peloton Equity with participation from SV Health Investors, BPEA Private Equity, and SOSV. The funding will be used to scale Ria's clinical model and payor coverage, accelerate sales and marketing, and strengthen its position in the continuum of AUD care; Peloton partner Michael O'Rourke will join Ria's board.

  • Buyer
    Empower Physical Therapy, Sheridan Capital Partners, SV Health Investors
    Target
    Doctors of Physical Therapy
    Type
    Addon

    Empower Physical Therapy has combined with Doctors of Physical Therapy (DPT) to create a larger outpatient and industrial physical therapy network. The deal, which closed in December 2024, brings DPT's more than 100 locations and 300+ practitioners into Empower's platform (backed by Sheridan Capital Partners) and will be supported going forward by Sheridan Capital Partners and SV Health Investors; Aaron Kraai (founder of DPT) will serve as CEO of the combined company.

  • Buyer
    Jet Health, Inc., SV Health Investors, Health Enterprise Partners
    Target
    Blessings Hospice
    Seller
    James Santiago (Founder and Owner of Blessings Hospice)
    Type
    Addon

    Jet Health, Inc. (Fort Worth, TX) has acquired Blessings Hospice, an Arlington, Texas-based hospice provider founded in 2019. The deal — Jet Health's fifth hospice-related acquisition — was funded by SV Health Investors and Health Enterprise Partners and expands Jet Health's hospice footprint across Texas.

  • Buyer
    Centauri Health Solutions, Abry Partners, Silversmith Capital Partners, SV Health Investors
    Target
    Secure Exchange Solutions
    Type
    Addon

    Centauri Health Solutions has acquired Secure Exchange Solutions (SES), a Rockville, Maryland-based provider of cloud-based clinical data exchange software. The acquisition, supported by Centauri's investors Abry Partners, Silversmith Capital Partners and SV Health Investors, expands Centauri's capabilities in clinical data exchange to complement its analytics, risk adjustment and revenue cycle solutions.

  • Buyer
    Welsh, Carson, Anderson & Stowe, Intermountain Ventures, Novant Health, Rex Health Ventures, Spectrum Health Ventures, UNC Health, Kaiser Permanente Ventures, Mayo Clinic, Frazier Healthcare Partners, SV Health Investors, H.I.G. BioHealth Partners
    Target
    Leiters
    Seller
    Kaiser Permanente Ventures, Mayo Clinic, Frazier Healthcare Partners, SV Health Investors, H.I.G. BioHealth Partners
    Industry
    Pharmaceuticals
    Type
    Buyout

    Welsh, Carson, Anderson & Stowe (WCAS) acquired a majority ownership stake in Leiters, an FDA-registered 503B outsourced pharmaceutical compounding provider. WCAS invested alongside health system investors including Intermountain Ventures, Novant Health, Rex Health Ventures, Spectrum Health Ventures and UNC Health, while existing investors — including Kaiser Permanente Ventures, Mayo Clinic, Frazier Healthcare Partners, SV Health Investors and H.I.G. BioHealth Partners — made reinvestments to support Leiters' growth, facility expansion and new product development.

  • Buyer
    Jet Health, Inc., SV Health Investors, Health Enterprise Partners, Stifel Bank
    Target
    Signal Home Health & Hospice
    Seller
    Robert McDowell
    Type
    Addon

    Fort Worth-based Jet Health, Inc. has acquired Signal Home Health & Hospice, a San Antonio provider of home health and hospice services. The deal — Jet Health's seventh acquisition — expands the company's presence in Texas; financing was provided by Stifel Bank, SV Health Investors and Health Enterprise Partners. Terms were not disclosed and the seller was owner Robert McDowell.

  • Buyer
    SV Health Investors, LLC
    Target
    Health Payment Systems, Inc.
    Seller
    Caltius Equity Partners

    SV Health Investors has completed a recapitalization of Caltius Equity Partners' investment in Health Payment Systems (HPS). The investment will support HPS' expansion in the Upper Midwest and beyond and includes leadership additions with Tom Policelli named CEO and Tom Flynn joining HPS' board.

  • Buyer
    Jet Health, Inc., SV Health Investors, Health Enterprise Partners
    Target
    Carrington Hospice Care, Inc.
    Type
    Addon

    Irvine-based home health provider Jet Health, Inc. acquired Arlington, Texas–based Carrington Hospice Care, Inc., expanding Jet Health's hospice footprint and enabling greater continuity of care for patients transitioning from home health to hospice. The transaction was financed by private equity investors SV Health Investors and Health Enterprise Partners; terms were not disclosed.

Related Acquisition Pages

Selling a company? Get in front of buyers like SV Health Investors

Turn tracked acquisition activity into an outreach-ready buyer list.